-
Zoledronic acid, also
known as
zoledronate and sold
under the
brand name
Zometa among others, by
Novartis among others, is a
medication used to
treat a...
-
prevent bone m**** loss and are
often used to
treat osteolytic lesions.
Zoledronic acid (Reclast) is a
specific drug
given to
cancer patients to prevent...
-
denosumab or 4 mg of
zoledronic acid.
Patients who were
given 120 mg of
denosumab (in
comparison to
those who were
given 4 mg of
zoledronic acid)
showed a greater...
- metastases. A 2012 meta-analysis
found that
denosumab was
better than placebo,
zoledronic acid, and pamidronate, in
reducing the risk of
fractures in
those with...
-
Tiludronic acid M05BA06
Ibandronic acid M05BA07
Risedronic acid M05BA08
Zoledronic acid M05BB01
Etidronic acid and calcium,
sequential M05BB02 Risedronic...
- the
plasma cell proliferation,
bisphosphonates (e.g.,
pamidronate or
zoledronic acid) are
routinely administered to
prevent fractures; they have also...
-
following two
intravenous and
three oral bisphosphonates, respectively:
zoledronic acid and
pamidronate and alendronate, risedronate, and ibandronate. Despite...
- Vaz
Wicks CL (2023-03-01). "Adrenal
Crisis as An
Adverse Reaction to
Zoledronic Acid in a
Patient With
Primary Adrenal Insufficiency: A Case
Report and...
- can
reduce pain as they
shrink tumors.
Other bone
modifying agents like
zoledronic acid and
denosumab can
reduce prostate cancer bone pain, even
though they...
-
Gauthier K, Bai A,
Perras C, et al. (2012). "Denosumab, Raloxifene, and
Zoledronic Acid for the
Treatment of
Postmenopausal Osteoporosis:
Clinical Effectiveness...
